Ischaemic colitis during interferon treatment for chronic hepatitis C: Report of two cases and literature review

Journal of Viral Hepatitis

Volumn 19, Issue 2, 2012, Pages

  Kawaguchi, T ^a   Ide, T ^a   Itou, M ^a   Suetsugu, M ^a   Yoshioka, S ^a   Sakata, M ^a   Taniguchi, E ^a   Oriishi, T ^a   Sumie, S ^a   Tsuruta, O ^a,b   Sata, M ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY HOSPITAL   (Japan)

Author keywords

adverse effect; hepatitis C virus; interferon; ischaemic colitis; melena

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; ALPHA2B INTERFERON; INTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; COLON BIOPSY; COLONOSCOPY; DRUG WITHDRAWAL; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; ISCHEMIC COLITIS; LIVER FUNCTION TEST; MEDICAL HISTORY; MEDICAL LITERATURE; PRIORITY JOURNAL; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; TREATMENT RESPONSE; WOUND HEALING;

COLITIS, ISCHEMIC; COLONOSCOPY; FEMALE; HEPATITIS C, CHRONIC; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOLOGIC FACTORS; INTERFERONS; MICROSCOPY; MIDDLE AGED; TREATMENT OUTCOME; WITHHOLDING TREATMENT;

EID: 84855832683     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01501.x     Document Type: Article

References (23)

1. Cross TJ, Rashid MM, Berry PA, Harrison PM,. The importance of steatosis in chronic hepatitis C infection and its management: a review. Hepatol Res 2010; 40 (3): 237-247.
2. Ghany MG, Strader DB, Thomas DL, Seeff LB,. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49 (4): 1335-1374.
3. Lauer GM, Walker BD,. Hepatitis C virus infection. N Engl J Med 2001; 345 (1): 41-52. (Pubitemid 32634271)
4. Kumada H, Okanoue T, Onji M, et al. Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan. Hepatol Res 2010; 40 (1): 8-13.
5. Poynard T, Yuen MF, Ratziu V, Lai CL,. Viral hepatitis C. Lancet 2003; 362 (9401): 2095-2100. (Pubitemid 38035201)
6. Fried MW,. Side effects of therapy of hepatitis C and their management. Hepatology 2002; 36 (5 Suppl 1): S237-S244. (Pubitemid 35253486)
7. Okanoue T, Sakamoto S, Itoh Y, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 1996; 25 (3): 283-291. (Pubitemid 26323465)
8. Tada H, Saitoh S, Nakagawa Y, et al. Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C. J Gastroenterol 1996; 31 (4): 582-584. (Pubitemid 26288430)
9. Reissfelder C, Sweiti H, Antolovic D, et al. Ischemic colitis: who will survive? Surgery 2011; 149(4): 585-592.
10. Horigome H, Takezono Y, Fujino N, Uchida A, Murasaki G,. A case of ischemic colitis associated with interferon treatment. Nippon Shokakibyo Gakkai Zasshi 1996; 93 (3): 181-184.
11. Fukushima Y, Funahashi H, Aoyagi Y, Satou T, Tubo K, Ozawa T,. Ischemic colitis during interferon treatment for chronic hepatitis C. Prog Dig Endosc 2004; 64 (2): 120-121.
12. Leung Y, Urbanski SJ, Schindel L, Myers RP,. Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Can J Gastroenterol 2006; 20 (10): 661-663. (Pubitemid 44781905)
13. Iwamatsu H, Tsunajima K, Saitoh R, et al. A case of ischemic colitis occurring in pegylated interferon-alfa-2b and ribavirin therapy for chronic hepatitis C. Endosc Forum Dig Dis 2008; 24 (2): 112-116.
14. Punnam SR, Pothula VR, Gourineni N, Punnam A, Ranganathan V,. Interferon-ribavirin-associated ischemic colitis. J Clin Gastroenterol 2008; 42 (3): 323-325. (Pubitemid 351301501)
15. Mosele M, Cardin F, Inelmen EM, et al. Ischemic colitis in the elderly: predictors of the disease and prognostic factors to negative outcome. Scand J Gastroenterol 2010; 45 (4): 428-433.
16. Nakamura T, Yamamura J, Sato H, Kakinuma H, Takahashi H,. Vasculitis induced by immunization with Bacillus Calmette-Guerin followed by atypical mycobacterium antigen: a new mouse model for Kawasaki disease. FEMS Immunol Med Microbiol 2007; 49 (3): 391-397. (Pubitemid 46435017)
17. Okuda Y, Takasugi K, Imai A, et al. Two cases of rheumatoid arthritis complicated with vasculitis-induced ischemic enterocolitis. Ryumachi 1990; 30 (5): 403-407.
18. Sparano JA, Dutcher JP, Kaleya R, et al. Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alpha. Cancer 1991; 68 (7): 1538-1544.
19. Morshed SA, Fukuma H, Kimura Y, Watanabe S, Nishioka M,. Interferon-gamma, interleukin (IL)-2 and IL-2 receptor expressions in hepatitis C virus-infected liver. Gastroenterol Jpn 1993; 28 (Suppl 5): 59-66. (Pubitemid 23215463)
20. Su K, Chen F, Yan WM, et al. Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma. World J Gastroenterol 2008; 14 (39): 5980-5989.
21. Vaddi K, Nicolini FA, Mehta P, Mehta JL,. Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation. Circulation 1994; 90 (2): 694-699. (Pubitemid 24242734)
22. Zeidman A, Dicker D, Mittelman M,. Interferon-induced vasospasm in chronic myeloid leukaemia. Acta Haematol 1998; 100 (2): 94-96. (Pubitemid 28482570)
23. Sasaki M, Sata M, Ishibashi M, Uchimura N, Tanikawa K,. Decreased regional cerebral blood flow during interferon therapy. Hepatol Res 1997; 9: 1-8. (Pubitemid 28023383)